Uveitis refers to an autoimmune eye disease that causes inflammation in the uvea of the eye. Uveitis is considered to be one of the leading cause of blindness in the U.S. According to the Ocular Immunology and Uveitis Foundation in 2016, Uveitis is the third leading cause of blindness in the U.S. having affecting approximately 38 cases per 100,000 population. The three common types of uveitis are anterior uveitis (swelling of the uvea towards the front of the eye), intermediate uveitis (swelling in the middle of the eye), and posterior uveitis (swelling of the uvea towards the back of the eye). Panuveitis refers to a case in which all three areas of the eye are affected by inflammation. The most common type among the three is the anterior uveitis.
Market Dynamics
Major factors driving growth of the global uveitis treatment market include rising incidence of uveitis and complications associated with the disease. According to a survey published in research journal of JAMA Ophthalmology, non-infectious uveitis was reported in 121 cases per 100,000 adults and 29 per 100,000 children in 2016. Various other factors supporting the market growth include rising expenditure in research and development for new therapies to treat uveitis as well as speedy approvals from U.S. FDA for the drugs in pipeline to treat the condition. However, factors such as irreversible blindness in some cases due to side effects of medications and other such medical conditions can thus, hinder the market growth for global uveitis treatment. The side effects associated with corticosteroids include high blood pressure, kidney damage, skin disorders, and others.
Key features of the study:
This report provides in-depth analysis of uveitis treatment market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017–2025), considering 2016 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global uveitis treatment market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
Key companies covered as a part of this study include AbbVie, Inc., Novartis AG, Eyegate Pharmaceuticals, Inc., Santen Pharmaceuticals, Allergan Plc, Regeneron Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Inc., and Alimera Sciences
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The global uveitis treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision making through various strategy matrices used in analyzing the uveitis treatment Market
Detailed Segmentation:
Global Uveitis Treatment Market, By Treatment:
Corticosteroids
Immunosuppressants
Monoclonal Antibodies
Cycloplegic Agents
Antibiotics
Antifungals
Antivirals
Analgesics
Global Uveitis Treatment Market, By Disease Type:
Anterior Uveitis
Posterior Uveitis
Intermediate Uveitis
Panuveitis
Global Uveitis Treatment Market, By Cause:
Infectious Uveitis
Non-Infectious Uveitis
Global Uveitis Treatment Market, By Geography:
North America
By Treatment:
Corticosteroids
Immunosuppressants
Monoclonal Antibodies
Cycloplegic Agents
Antibiotics
Antifungals
Antivirals
Analgesics
By Disease Type:
Anterior Uveitis
Posterior Uveitis
Intermediate Uveitis
Panuveitis
By Cause:
Infectious Uveitis
Non-Infectious Uveitis
By Country:
U.S.
Canada
Europe
By Treatment:
Corticosteroids
Immunosuppressants
Monoclonal Antibodies
Cycloplegic Agents
Antibiotics
Antifungals
Antivirals
Analgesics
By Disease Type:
Anterior Uveitis
Posterior Uveitis
Intermediate Uveitis
Panuveitis
By Cause:
Infectious Uveitis
Non-Infectious Uveitis
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Treatment:
Corticosteroids
Immunosuppressants
Monoclonal Antibodies
Cycloplegic Agents
Antibiotics
Antifungals
Antivirals
Analgesics
By Disease Type:
Anterior Uveitis
Posterior Uveitis
Intermediate Uveitis
Panuveitis
By Cause:
Infectious Uveitis
Non-Infectious Uveitis
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Latin America
By Treatment:
Corticosteroids
Immunosuppressants
Monoclonal Antibodies
Cycloplegic Agents
Antibiotics
Antifungals
Antivirals
Analgesics
By Disease Type:
Anterior Uveitis
Posterior Uveitis
Intermediate Uveitis
Panuveitis
By Cause:
Infectious Uveitis
Non-Infectious Uveitis
By Country:
Brazil
Mexico
Rest of Latin America
Middle East
By Treatment:
Corticosteroids
Immunosuppressants
Monoclonal Antibodies
Cycloplegic Agents
Antibiotics
Antifungals
Antivirals
Analgesics
By Disease Type:
Anterior Uveitis
Posterior Uveitis
Intermediate Uveitis
Panuveitis
By Cause:
Infectious Uveitis
Non-Infectious Uveitis
By Country:
GCC
Israel
Rest of Middle East
Africa
By Treatment:
Corticosteroids
Immunosuppressants
Monoclonal Antibodies
Cycloplegic Agents
Antibiotics
Antifungals
Antivirals
Analgesics
By Disease Type:
Anterior Uveitis
Posterior Uveitis
Intermediate Uveitis
Panuveitis
By Cause:
Infectious Uveitis
Non-Infectious Uveitis
By Country:
South Africa
Central Africa
North Africa
Company Profiles
AbbVie, Inc.*
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Novartis AG
Eyegate Pharmaceuticals, Inc.
Santen Pharmaceuticals
Alimera Sciences
Regeneron Pharmaceuticals, Inc.
Valeant Pharmaceuticals International, Inc.
Allergan Plc
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objective and Assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
? Market Definition and Scope
o Executive Summary
? Market Snippet By Treatment
? Market Snippet By Disease Type
? Market Snippet By Cause
? Market Snippet By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
? Drivers
? Restraints
? Market Opportunities
? Market Trends
o Pipeline Analysis
o Novel Innovation in Uveitis Treatment
o Epidemiology
4. Global Uveitis Treatment Market, By Treatment, 2017 - 2025, (US$ Mn)
o Introduction
? Market Share Analysis, 2017 and 2025 (%)
? Y-o-Y Growth Analysis, 2017 - 2025
? Segment Trends
o Corticosteroids
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
o Immunosuppressant
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
o Monoclonal Antibodies
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
o Cycloplegic Agents
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
o Antibiotics
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
o Antivirals
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
o Antifungal
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
o Analgesics
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
5. Global Uveitis Treatment Market, By Disease Type, 2017 - 2025, (US$ Mn)
o Introduction
? Market Share Analysis, 2016 and 2025 (%)
? Y-o-Y Growth Analysis, 2017 - 2025
? Segment Trends
o Anterior Uveitis
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
o Posterior Uveitis
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
o Intermediate Uveitis
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
o Panuveitis
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
6. Global Uveitis Treatment Market, By Cause, 2017 - 2025, (US$ Mn)
o Introduction
? Market Share Analysis, 2017 and 2025 (%)
? Y-o-Y Growth Analysis, 2017 - 2025
? Segment Trends
o Infectious Uveitis
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
o Non- infectious Uveitis
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
7. Global Bone Graft and Substitutes Market, By Region, 2017 - 2025, (US$ Mn)
o Introduction
? Market Share Analysis, By Region, 2017 and 2025 (%)
? Y-o-Y Growth Analysis, For Regions, 2017 - 2025
o North America
? Market Size and Forecast, By Treatment, 2017 - 2025, (US$ Mn)
? Market Size and Forecast, By Disease Type, 2017 - 2025, (US$ Mn)
? Market Size and Forecast, By Cause, 2017 - 2025, (US$ Mn)
? Market Size and Forecast, By Country, 2017 - 2025, (US$ Mn)
? U.S.
? Canada
o Latin America
? Market Size and Forecast, By Treatment, 2017 - 2025, (US$ Mn)
? Market Size and Forecast, By Disease Type, 2017 - 2025, (US$ Mn)
? Market Size and Forecast, By Cause, 2017 - 2025, (US$ Mn)
? Market Size and Forecast, By Country, 2017 - 2025, (US$ Mn)
? Brazil
? Mexico
? Rest of Latin America
o Europe
? Market Size and Forecast, By Treatment, 2017 - 2025, (US$ Mn)
? Market Size and Forecast, By Disease Type, 2017 - 2025, (US$ Mn)
? Market Size and Forecast, By Cause, 2017 - 2025, (US$ Mn)
? Market Size and Forecast, By Country, 2017 - 2025, (US$ Mn)
? Germany
? U.K.
? France
? Italy
? Spain
? Russia
? Rest of Europe
o Asia Pacific
? Market Size and Forecast, By Treatment, 2017 - 2025, (US$ Mn)
? Market Size and Forecast, By Disease Type, 2017 - 2025, (US$ Mn)
? Market Size and Forecast, By Cause, 2017 - 2025, (US$ Mn)
? Market Size and Forecast, By Country, 2017 - 2025, (US$ Mn)
? China
? India
? Japan
? Australia
? South Korea
? ASEAN
? Rest of APAC
o Middle East
? Market Size and Forecast, By Treatment, 2017 - 2025, (US$ Mn)
? Market Size and Forecast, By Disease Type, 2017 - 2025, (US$ Mn)
? Market Size and Forecast, By Cause, 2017 - 2025, (US$ Mn)
? Market Size and Forecast, By Country, 2017 - 2025, (US$ Mn)
? GCC
? Israel
? Rest of Middle East
o Africa
? Market Size and Forecast, By Treatment, 2017 - 2025, (US$ Mn)
? Market Size and Forecast, By Disease Type, 2017 - 2025, (US$ Mn)
? Market Size and Forecast, By Cause, 2017 - 2025, (US$ Mn)
? Market Size and Forecast, By Country, 2017 - 2025, (US$ Mn)
? South Africa
? Central Africa
? North Africa
8. Competitive Landscape
o Heat Map Analysis
o Market Share Analysis (3x3 Matrix)
o Company Profiles
? Santen Pharmaceutical Co., Ltd.
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Regeneron Pharmaceuticals, Inc
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Allergan Plc
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Valeant Pharmaceutical International, Inc.
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Abbvie, Inc.
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Novartis AG
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Alimera Sciences
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
?
o Analyst Views
9. Section
o References
o Research Methodology
o About us and Sales Contact
*Browse 35 market data tables and 30 figures on "Global Uveitis Treatment Market - Global forecast to 2025".
Request Discount 
Inquire Before Buy
